PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Becker, M.* ; Strengert, M.* ; Junker, D.* ; Kaiser, P.D.* ; Kerrinnes, T.* ; Traenkle, B.* ; Dinter, H.* ; Häring, J.* ; Ghozzi, S.* ; Zeck, A.* ; Weise, F.* ; Peter, A. ; Hörber, S. ; Fink, S.* ; Ruoff, F.* ; Dulovic, A.* ; Bakchoul, T.* ; Baillot, A.* ; Lohse, S.* ; Cornberg, M.* ; Illig, T.* ; Gottlieb, J.* ; Smola, S.* ; Karch, A.* ; Berger, K.* ; Rammensee, H.G.* ; Schenke-Layland, K.* ; Nelde, A.* ; Märklin, M.* ; Heitmann, J.S.* ; Walz, J.S.* ; Templin, M.* ; Joos, T.O.* ; Rothbauer, U.* ; Krause, G.* ; Schneiderhan-Marra, N.*

Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity.

Nat. Commun. 12:1152 (2021)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The humoral immune response to SARS-CoV-2 is a benchmark for immunity and detailed analysis is required to understand the manifestation and progression of COVID-19, monitor seroconversion within the general population, and support vaccine development. The majority of currently available commercial serological assays only quantify the SARS-CoV-2 antibody response against individual antigens, limiting our understanding of the immune response. To overcome this, we have developed a multiplex immunoassay (MultiCoV-Ab) including spike and nucleocapsid proteins of SARS-CoV-2 and the endemic human coronaviruses. Compared to three broadly used commercial in vitro diagnostic tests, our MultiCoV-Ab achieves a higher sensitivity and specificity when analyzing a well-characterized sample set of SARS-CoV-2 infected and uninfected individuals. We find a high response against endemic coronaviruses in our sample set, but no consistent cross-reactive IgG response patterns against SARS-CoV-2. Here we show a robust, high-content-enabled, antigen-saving multiplex assay suited to both monitoring vaccination studies and facilitating epidemiologic screenings for humoral immunity towards pandemic and endemic coronaviruses.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
14.919
3.055
10
27
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Zeitschrift Nature Communications
Quellenangaben Band: 12, Heft: 1, Seiten: , Artikelnummer: 1152 Supplement: ,
Verlag Nature Publishing Group
Verlagsort London
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes Research and Metabolic Diseases (IDM)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502400-001
Förderungen European Union
Initiative and Networking Fund of the Helmholtz Association of German Research Centres
DOI 10.1038/s41467-021-20973-3
WOS ID WOS:000621486400007
Scopus ID 85101192431
PubMed ID 33608538
Erfassungsdatum 2021-04-26
[➜Korrektur melden]